KPL Expands BacTrace® Line

MILFORD, Mass., July 29, 2014 /PRNewswire/ -- KPL, a SeraCare Company, today announced the addition of three new products to its growing line of BacTrace antibodies: BacTrace^® Antibody Coated Latex Beads, BacTrace^® STEC Antibodies, and BacTrace^® Salmonella CSA-Plus Antibodies. These tools are designed for use by researchers and developers of foodborne pathogen assays. As polyclonals, the BacTrace antibodies can be used as capture or detection antibodies and offer higher sensitivity than commercially available monoclonal antibodies.

"KPL's BacTrace^® anti-bacteria antibodies have served as key tools for life scientists and diagnostic kit manufacturers in food pathology and infectious disease for 30 years," said Les Kirkegaard, Director of Marketing and Business Development at KPL. "By expanding our offerings, we are able to provide a range of benefits in the development of high performance immunoassays that help meet the needs of our customers."

KPL's new BacTrace STEC (Shiga Toxin-producing Escherichia coli) Antibodies are suited for a variety of immunodetection and immunoselection applications, utilizing the industry-proven ECAP (Encapsulated Column Affinity Purification) technology. Two new antibodies to E. coli O104 and O91 are being released.

KPL's BacTrace^® Latex Beads are easy-to-use tools that enable the qualitative detection of 6 different STEC serotypes and Salmonella serotypes. As the only coated latex beads utilizing the proven BacTrace STEC antibodies, results are obtained in just five minutes.

BacTrace^® Salmonella CSA-Plus Antibody offers the broadest specificity to Salmonella serogroups and is ideally suited for a variety of immunoassays and immunoseparation applications. This antibody provides assay developers and researchers a proven tool to detect Salmonella serogroups A, B, C, D, E and G with high sensitivity. It is an improved version of the commercially-proven anti-Salmonella CSA-1 antibody with enhanced reactivity to serogroups C2-C3 and G.

About KPL, a SeraCare Company
KPL develops, manufactures, and markets high quality immunochemicals for life science and in vitro diagnostics. KPL was the first company to commercialize affinity-purified secondary antibodies, a valuable tool for biological research and in vitro diagnostic testing. KPL has introduced over 800 reagents and complete assay kits for protein visualization and nucleic acid detection that address the needs of cell biology, immunology, protein chemistry, and molecular biology scientists. KPL was acquired by SeraCare Life Sciences in August 2013.
For more information, visit www.kpl.com.

About SeraCare Life Sciences, Inc.
SeraCare partners with diagnostics researchers, IVD manufacturers, and clinical laboratories to shape the future of medical diagnostics. Our innovative portfolio includes ACCURUN^® quality controls, research panels, KPL^™ antibodies and immunoassay reagents, SeraCon^™ processed plasma, specialty human blood products, and characterized disease state materials. SeraCare helps bridge the gap between today's diagnostic solutions and tomorrow's emerging technologies. For more information, visit www.seracare.com.

Logo - http://photos.prnewswire.com/prnh/20140725/130423

SOURCE SeraCare Life Sciences, Inc.